Literature DB >> 27499413

Attitudes to female genital mutilation/cutting among male adolescents in Ilorin, Nigeria.

Abiodun S Adeniran1, Munirdeen A Ijaiya, Adegboyega A Fawole, Olayinka R Balogun, Kikelomo T Adesina, Abdul Waheed O Olatinwo, Adebunmi O Olarinoye, Peace I Adeniran.   

Abstract

BACKGROUND: The central role of males in female reproductive health issues in patriarchal societies makes them an important group in the eradication of female genital mutilation/cutting (FGM/C).
OBJECTIVE: To determine knowledge about and attitudes to FGM/C among male adolescents, and their preparedness to protect their future daughters from it.
METHODS: A cross-sectional survey among male adolescent students in Ilorin, Nigeria. Participants completed a self-administered questionnaire after consent had been obtained from them or their parents. Statistical analysis was with SPSS version 20.0 (IBM, USA). A p-value of <0.05 was taken as significant.
RESULTS: Of 1 536 male adolescents (mean age 15.09 (standard deviation 1.84) years, range 14 - 19), 1 184 (77.1%) were aware of FGM/C, 514 (33.5%) supported female circumcision, 362 (23.6%) would circumcise their future daughters, 420 (27.3%) were of the opinion that FGM/C had benefits, mostly as a necessity for womanhood (109, 7.1%), and 627 (40.8%) perceived it as wickedness against females; 546 (35.5%) were aware of efforts to eradicate FGM/C, and 42.2% recommended education as the most important intervention to achieve this.
CONCLUSION: Education and involvement in advocacy may transform male adolescents into agents for eradication of FGM/C.

Entities:  

Year:  2016        PMID: 27499413     DOI: 10.7196/SAMJ.2016.v106i8.10124

Source DB:  PubMed          Journal:  S Afr Med J


  1 in total

1.  Female adolescents and the future of female genital mutilation/cutting: a report from an endemic area.

Authors:  Grace G Ezeoke; Abiodun S Adeniran; Kikelomo T Adesina; Adegboyega A Fawole; Munirdeen A Ijaiya; Adebunmi O Olarinoye
Journal:  Afr Health Sci       Date:  2021-12       Impact factor: 1.108

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.